You have 9 free searches left this month | for more free features.

atezolizumab

Showing 26 - 50 of 295

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Squamous Cell Carcinoma, Urinary Tract Cancer Trial (Atezolizumab)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Urinary Tract Cancer
  • Atezolizumab
  • (no location specified)
Sep 7, 2021

Colorectal Cancer Trial in Essen (Atezolizumab)

Recruiting
  • Colorectal Cancer
  • Atezolizumab
  • Essen, Germany
    Westdeutsches Tumorzentrum
Feb 14, 2022

NSCLC Stage IV, NSCLC, Recurrent Trial in Fairway, Kansas City (Atezolizumab)

Not yet recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Atezolizumab
  • Fairway, Kansas
  • +1 more
Jan 20, 2022

Unresectable Hepatocellular Carcinoma Trial in Boston (Atezolizumab, Bevacizumab, Stereotactic body radiation therapy (SBRT))

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 26, 2021

Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

Not yet recruiting
  • Metastatic Papillary Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Atezolizumab
  • Cabozantinib S-malate
  • (no location specified)
Jun 28, 2022

Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)

Recruiting
  • Invasive Bladder Cancer
  • Madrid, Spain
    Hospital 12 de Octubre
Feb 8, 2022

Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Birmingham, Alabama
  • +2 more
Feb 21, 2022

Non Small Cell Lung Cancer Trial in Durham (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
May 23, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Houston (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Hepatocellular Cancer
  • Houston, Texas
    Houston Methodist Research Institute
Jan 5, 2022

Tumor, Solid Trial in United States (BDB001, Atezolizumab)

Active, not recruiting
  • Tumor, Solid
  • Los Angeles, California
  • +4 more
Jul 6, 2022

Ovarian Endometrioid Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Ovarian Endometrioid Tumor
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 21, 2021

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Atezolizumab
  • +4 more
  • Frankfurt, Germany
  • +1 more
Apr 14, 2022

Cervical Cancer Trial in Leuven (Atezolizumab, Doxorubicin)

Active, not recruiting
  • Cervical Cancer
  • Leuven, Belgium
    UZLeuven
Jan 26, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Advanced Hepatocellular Carcinoma Trial in Singapore (MTL-CEBPA, Atezolizumab, Bevacizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Singapore, Singapore
    National University Hospital
Oct 27, 2021

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Atezolizumab
  • +4 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Small Cell Lung Cancer Extensive Stage, Thoracic Radiotherapy Trial in Linz, Heidelberg (Atezolizumab, thoracic radiotherapy

Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Thoracic Radiotherapy
  • Atezolizumab
  • thoracic radiotherapy (TRT)
  • Linz, Austria
  • +1 more
Aug 25, 2021

NSCLC Stage IV Trial in Bellinzona, Chur, Geneva (Atezolizumab)

Recruiting
  • NSCLC Stage IV
  • Atezolizumab
  • Bellinzona, Switzerland
  • +2 more
Apr 26, 2022

Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston (Atezolizumab, Cobimetinib,

Recruiting
  • Recurrent Breast Inflammatory Carcinoma
  • Stage IV Breast Inflammatory Carcinoma
  • Atezolizumab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2021

Solid Tumor, Metastatic Cancer Trial in United States (TJ004309, Atezolizumab)

Active, not recruiting
  • Solid Tumor
  • Metastatic Cancer
  • Birmingham, Alabama
  • +3 more
Mar 31, 2022

NSCLC, Non-small Cell Carcinoma, NSCLC Trial (Ramucirumab, Atezolizumab, N-803)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 28, 2021

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Hackensack, New Jersey
  • +3 more
Jan 21, 2022

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Atezolizumab
  • +2 more
  • San Francisco, California
  • +1 more
Feb 14, 2022

Hepatocellular Carcinoma Trial in Korea, Republic of, United States (SRF388, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Duarte, California
  • +3 more
Aug 15, 2022

Rectal Tumors Trial in Belgium (Atezolizumab, 5-FU based radio-chemo)

Recruiting
  • Rectal Neoplasms
  • Atezolizumab
  • 5-FU based radio-chemotherapy
  • Charleroi, Hainaut, Belgium
  • +4 more
Apr 6, 2022